8 NEWS
Twenty years of R&D software support
Cosmetic R&D software company, Coptis, is celebrating its 20th anniversary. Founded in 1999 by Anne Karagoz, President, the company is headquartered in Croissy sur Seine, Paris with subsidiaries in New York and Singapore. The company is
commemorating this milestone with customer focused events planned for various locations throughout the year. These celebrations provide an
opportunity to acknowledge and appreciate Coptis’ customers, the Coptis sales team and partners that have been integral to its global accomplishment. “Our success and longevity
are due in part to the advanced capabilities and continuous evolution of our products,” said President and founder, Anne Karagoz. “More than 3,000 people currently use our software worldwide, and our customer training takes place on
four continents”.
Coptis Lab satisfies growing demand for an integrated system for formulation development and regulatory affairs designed specifically for the cosmetic industry. Coptis offerings are further optimised by complementary products, Coptis Ingredients, Coptis Tox and Coptis Tab, developed and introduced to enhance the value of its flagship product, Coptis Lab.
Innovation centre to open near NYC
Clariant announced plans to open a state-of-the-art consumer care innovation centre near New York City in mid-2019. “We strive to provide the best customer experience and reliable customer fulfilment. Having this centre in place will enhance our ability to do so for our global personal and home care as well as healthcare customers, and especially for those located in the New York City area. By intensifying cooperation, we can deliver products with more substantiated claims on
customer formulations that provide the basis for a successful and mutually beneficial relationship and drive growth for Clariant in North America,” said Ernesto Occhiello, CEO of Clariant.
The new CCIC is set to start its activities in July 2019 and will be located in New Providence, NJ, US, which gives it access to many key customers and key players located in the New York- New Jersey Metro area. The 1,333 sq. meter (14, 350 sq. foot) facility will incorporate state-of- the-art spaces such as a demonstration room, a high-tech
Upgrade for new plant
MFG Chemical, who operate in specialty and custom chemical manufacturing, has upgraded its Pasadena, Texas plant, which the company acquired in March 2018, and sits on 24.5 acres. The acquisition of the
Pasadena plant, together with the company’s three plants in Northwest Georgia, makes MFG Chemical one of America’s largest consumers of maleic anhydride. Pasadena plant improvements
were completed the end of the 1st Quarter of 2019, and entail a
PERSONAL CARE EUROPE
multi-million dollar investment. Improvements include debottlenecking and new capacity additions, including two new reactors, one of which is 20,000 gallons in size. Keith Arnold, CEO of MFG
Chemical and Member of the SOCMA Board of Governors, commented: “MFG is increasing its capacity to meet its customers’ growing needs for custom and specialty chemistries. Our significant capital investments in our Pasadena, TX, plant as well as our three other world-class ISO 9001:2015 Certified
manufacturing plants in Dalton, GA reflect our ongoing effort to deepen our manufacturing and formulating partnerships with our valued customers.”
application and claims laboratory, a testing centre where lab results can be correlated with actual consumer perceivable testing and a collaboration space for interactive and creative thinking.
Biopolymer business acquired
Givaudan has announced that it has reached an agreement to acquire the cosmetics business of AMSilk GmbH. AMSilk is the world’s first industrial supplier of vegan silk biopolymers and has its headquarters near Munich, Germany. AMSilk offers a range of high-performance biosourced polypeptides with unique functional properties in the field of cosmetics. These vegan biopolymers offer a broad range of applications across categories such as hair care and skin care with benefits like silk touch, anti-pollution, or colour protection of the hair. Over the years, they have filed 10 patents for the use of biopolymers in cosmetic applications. Maurizio Volpi, President of Givaudan’s Fragrance Division said: “The acquisition of the cosmetics business of AMSilk fits very well our long term strategy for Active Beauty. It offers an expanded portfolio of natural and biosourced products supported by a strong research and development biotechnology platform to drive future development and innovation in the active cosmetic ingredients space. Their expertise in
biotechnology is fully aligned with ours; it will reinforce Givaudan’s capabilities in cosmetic ingredients to support our customers in developing sustainable, performant and safe products.”
Jens Klein, CEO of AMSilk added: “We are honoured that Givaudan is acquiring our successful cosmetics business to further expand internationally to reach even more consumers around the world with our functional biopolymers.”
June 2019
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84
